Feedback-inhibition of glucagon-stimulated glycogenolysis in hepatocyte/kupffer cell cocultures by glucagon-elicited prostaglandin production in kupffer cells U n i v e r s i t ä t P o t s d a m
Prostaglandins (PGs) produced by nonparenchymal liver are involved in the regulation of liver carbohydrate metabolism. They mediate the mobilization of glucose from the liver in response to inflammatory ~t i m u l i ,~ e.g., z y m o~a n ,~ endotoxins,6 immune comp l e~e s ,~ platelet activating factor,' and anaphylotoxins.g PGs increased inositol triphosphate (InsP,) formation, glycogen phosphorylase activity, and glucose output in hepatocyte cultures and suspensions. [10] [11] [12] This glycogenolytic effect was mediated by PGFzu receptors and PGE2 receptors of the EP1 subtype that are linked to phospholipase C by a pertussis toxin-insensitive G-protein. 12 In addition, primarily PGEz and to a lesser extent also PGF2, and PGDz inhibited the glucagon-stimulated cyclic adenosine monophosphate (CAMP) formation,', glycogen phosphorylase activity,12 glucose mobilization from g l y~o g e n , '~,~~ and gluconeogenesis12 in hepatocytes. This glucagon-antagonistic effect was mediated by PGE2 receptors of the EP3 subtype,12 that are linked to adenylate cyclase by a pertussis toxin-sensitive Gi-protein. 16 -l' Therefore, PGs especially PGE2, may be involved in a feedback inhibition of glucagon-stimulated glucose mobilization from hepatocytes, if PGs were formed in a glucagon-dependent manner in the liver.
Because glucagon receptors have been detected on Kupffer cells in binding studies, 19 it appeared possible that they might be involved in a glucagon-stimulated PG formation and thus the proposed feedback loop. The current study provides evidence for such a mechanism: glucagon stimulated PG formation in Kupffer cells and caused a greater increase in glycogenolysis in hepatocyte monocultures than in hepatocyteKupffer cell CO- At the end of the experiment, Kupffer cells were scraped off the dish for DNA determination in a fluorescence assay based on the intercalation of bis-benzimide into DNA.24 For determination of CAMP formation, Kupffer cell cultures were treated similarly except that at the end of a 2-minute incubation period, after addition of glucagon or vehicle, medium was removed, and cells were shock-frozen in liquid nitrogen. CAMP was extracted from these cells with 500 pL 10 mmoVL HC1 containing 1 mmoVL isobutyl-methyl-xanthine (IBMX). CAMP was determined with a l"I-radioimmunoassay according to the instructions of the supplier. Determination of InsP3 Formation in Kupffer Cells. After 48 hours of culture, medium was replaced by inositol-free RPMI medium supplemented as described above containing in addition 10 pCi/mL [3H]myoinositol. Culture was continued for another 24 hours to label inositol-phospholipids. Medium was removed, cells were washed five times with Hank's balanced salt solution, and then incubated for 10 minutes at 37°C in the same buffer containing in addition 10 mmoVL LiCl to inhibit degradation of inositol phosphates. Glucagon (1 nmoVL final concentration) was added. After 3 minutes, medium was removed and cells were frozen in liquid nitrogen. Inositol phosphates were extracted with 350 pL 7.5% TCA.
Inositol phosphates were separated on Dowex formate 1 x 8 as described previouslyz5; briefly, TCA was removed from the samples by 3 extractions with a 10-fold volume of ethylether. The water phase was diluted fourfold and applied to 1.5 mL (moist volume) Dowex formate in a small column. Inositol and inositol phosphates were eluted subsequently with 6 mL HzO (inositol), 4 
RESULTS

Stimulation by Glucagon of PG Formation in Kupffer
Cells. In Kupffer cells that had been cultured for 72 hours on untreated plastic dishes, glucagon (10 nmoV L) increased the formation of PGEz, PGFz,, and PGDz. The increase was rapid in onset and transient, so that the PG concentrations in the medium remained increased over a period of 10 minutes (Fig. 1) . The increase was dose-dependent; concentrations of glucagon that are known to stimulate glycogenolysis in hepatocytes and that can occur in portal blood, i.e., 0.1 to 1 nmol/L, already enhanced PG formation nearly to the maximum (Fig. 2) . Glucagon also increased PG formation in Kupffer cells cultured on collagen-coated plates to the same extent as on uncoated tissue culture plates (not shown).
Kupffer cells were treated with acetylsalicylic acid (ASA) (500 pmoVL) for 30 minutes. ASA was then removed.by three washes, and the cells incubated another 10 minutes without ASA. They were then stimulated with 1 nmol/L glucagon. Under these conditions basal PG formation was reduced to less than detection limit, and PG formation was no longer stimulated by glucagon (not shown).
Glucagon (1 nmoVL) increased CAMP formation in Kupffer cells fivefold over basal within 2 minutes (Table 1). In Kupffer cells that had been labelled with [3H]myoinositol for 24 hours, glucagon (1 nmol/L) increased [3H]inositol-trisphosphate formation in presence of 10 mmoVL LiCl twofold over basal within 3 minutes ( Table 1) . In contrast to zymosan, no further increase in InsP, formation was observed during prolonged incubation (not shown). 
Stimulation by Glucagon of Glycogen Phosphorylase
Activity i n HepatocytelKupffer Cell Cocultures. To test the working hypothesis that PGs released from Kupffer cells in response to glucagon might feedback inhibit glucagon-stimulated glycogen phosphorylase activity in hepatocytes, a coculture system of Kupffer cells and hepatocytes was established.
Kupffer cells were cultured on collagen-coated culture dishes for 48 hours. Then hepatocytes were seeded on top of the Kupffer cells. Culture was continued for another 24 hours before the experiment. Parallel to Kupffer cellhepatocyte cocultures, Kupffer cell monocultures and hepatocyte monocultures were maintained on collagen-coated culture dishes (Fig. 3 ) . There was no difference in morphology of hepatocytes in cocultures and monocultures. Kupffer cells in cocultures seemed to contain somewhat more phagocytosed material, probably debris of dead hepatocytes. Cocultures contained the same number of hepatocyteddish as control hepatocyte monocultures and the same number of Kupffer cellddish as control Kupffer cell monocultures. The DNA content in cocultures (13.5 pg/dish) was about the sum of the DNA content in Kupffer cell (3.7 pg/ dish) and hepatocyte (8.5 pg/dish) monocultures (Fig.  3) . Thus, it could be assumed that between 60% and 70% of the total DNA of cocultures were to be ascribed to hepatocyte DNA. For all further calculations the fraction of hepatocyte DNA in cocultures was set equal t o 65%. When related to hepatocyte DNA, basal glycogen phosphorylase activity was identical in hepatocyte monocultures and hepatocyte/Kupffer cell cocultures (1.86 +-0.24 U x mg hepatocyte DNA-' vs. 1.89 t 0.26 U x mg hepatocyte DNA-l). Glucagon stimulated glycogen phosphorylase activity in hepatocyte monocultures by threefold over basal. Yet, in hepatocytemupffer cell cocultures, glucagon increased glycogen phosphorylase activity only by twofold over basal (Fig. 4) . There was no appreciable degradation of glucagon either in hepatocyte monocultures or hepatocyte/ Kupffer cell cocultures during the course of the experiment (not shown). PGE, added concomitantly with glucagon, reduced the glucagon-stimulated glycogen phosphorylase activity in hepatocyte monocultures by 25%. However, addition of PGE, did not further reduce the glucagon effect in hepatocyteKupffer cell cocultures (Fig. 4) . Thus, it seemed possible that endogenously released PGs attenuated the glucagon-stimulated glycogen phosphorylase activity in cocultures.
To corroborate this hypothesis, cell cultures were incubated with 500 pmol/L ASA for 30 minutes. This treatment completely and irreversibly inactivated PGH   FIG. 3 . HepatocyteKupffer cell cocultures. Rat Kupffer cells were prepared as in Fig. 1 and cultured for 48 hours on collagen-coated tissue culture dishes. Medium was changed every 24 hours. Hepatocytes were prepared by calcium-free ethylenediaminetetraacetic acid liver perfusion without the use of collagenase. They were purified by Percoll gradient centrifugation and either seeded on top of Kupffer cell cultures or on separate collagen-coated culture dishes. Culture was continued for another 24 hours with a medium change after 4 hours. The DNA content was determined by a fluorometric assay.
Stimulation by glucagon of glycogen phosphorylase activity in hepatocyte cultures and hepatocyteKupffer cell cocultures. Hepatocyte and Kupffer cell cultures as well as hepatocyteKupffer cell cocultures were prepared and maintained for 72 hours as in Fig.  3 . Medium was then replaced by fresh serum-free medium containing 500 kmoVL ASA when indicated. Cells were incubated for 30 minutes and medium replaced by a HEPES-buffered balanced salt solution. After a preincubation period of 10 minutes, cells were stimulated with 1 nmol/L glucagon or 10 ,umol/L PGE, or both. After 2 minutes, buffer was removed and cells were frozen in liquid nitrogen for later determination of glycogen phosphorylase in a standard assay. Values are means t SEM of four independent experiments. HC, hepatocyte mono-culture; Cocu, hepatocyteKupffer cell co-culture; G, glucagon; E, PGE,. Statistics: Student's t-test for unpaired samples, (a) P < .01; (b) P < .05. synthases in Kupffer cells (see previously). ASA was then removed, and after another 10 minutes, cell cultures were stimulated with glucagon. In ASA-treated hepatocyte monocultures and hepatocyteKupffer cell cocultures, basal glycogen phosphorylase activity was somewhat less than in untreated cultures (1.56 ? 0.26 U X mg hepatocyte DNAp1 and 1.44 ? 0.21 U X mg hepatocyte DNAp1). In ASA-treated, as in untreated hepatocyte monocultures, glucagon increased glycogen phosphorylase activity by threefold. However, in contrast to untreated cocultures, glucagon increased glycogen phosphorylase activity in ASA-treated hepatocyte/ Kupffer cell cocultures also by threefold (Fig. 4) . Thus, ASA treatment abolished the difference of glucagonstimulated glycogen phosphorylase activity between hepatocyte monocultures and hepatocyteKupffer cell cocultures. Surprisingly, ASA treatment also abolished the attenuation by PGE2 of glucagon-stimulated glycogen phosphorylase activity in hepatocyte monocultures. This effect is not understood and most likely cannot be ascribed to the inactivation of PGH synthase.
DISCUSSION
Functional Role of the Glucagon Receptor on Kupffer
Cells. Glucagon receptors have previously been shown on Kupffer cells by electron microscopy using glucagon that had been cross-linked to gold particles via albumin and also in [12511glucagon-binding studies." The electron microscopical studies showed that glucagon receptors were internalized via a clathrin-independent pathway and that the endocytotic vesicles were fused with lysosomes. Therefore, glucagon receptors on Kupffer cells have been implicated in intrahepatic glucagon degradation; however, only a minor fraction (20%) of ['2511glucagon was degraded by Kupffer cells in suspension within 1 hour at 37"C.l' Similarly, in the current study, no appreciable glucagon degradation could be observed in Kupffer cell cultures within 2 minutes. Therefore, the role of Kupffer cells in glucagon degradation is doubtful. Thus, the glucagon-elicited PG release shown in the current study ( Figs. 1 and 2 ) appears to be the first example for a physiological role of glucagon receptors on Kupffer cells.
Mechanism of the Glucagon-Induced PG Release
From Kupffer Cells. The glucagon receptor appears to be coupled to two intracellular signalling pathways; the ligand occupied receptor stimulates the adenylate cyclase and also increases the cytosolic Ca2+ concentration and InsP, f o r m a t i~n .~~,~~ Accordingly, glucagon increased both CAMP formation by fivefold and InsPs formation by twofold in Kupffer cells (Table 1 ). In previous studies glucagon was found to only slightly increase CAMP formation in Kupffer cells. This increase was very small compared with the increase in total liver plasma membranes." In purified Kupffer cell plasma membranes, no increase in adenylate cyclase activity in response to glucagon could be dete~ted.~' In the older studies, it remained unclear what the physiological meaning of the glucagon-dependent increase in CAMP could be. Later, extracellularly applied dibutyryl CAMP was shown to attenuate zymosan-stimulated and phorbol ester-stimulated but not calcium ionophore-stimulated PG formation by about 50%.,' The increase in CAMP formation that is also elicited by PGs in Kupffer cells has been implicated as a possible negative feedback loop of PG f~rmation.~' Glucagon would thus elicit an inhibitory signal for PG formation in Kupffer cells. However, protein kinase A-dependent phosphorylation of cytosolic phospholipase A2 (cPLA2) has also been shown to activate this key regulatory enzyme of arachidonic acid and thus PG s y n t h e s i~,~~~~~ even though the increase in activity was small compared with activation with MAP k i n a~e . ,~ Therefore, it seems to be possible that the glucagon-mediated increase in CAMP formation in Kupffer cells could also increase basal PG formation. In line with this hypothesis, dibutyl CAMP applied in high concentrations (1 mmol/L) to Kupffer cell cul- On the other hand, activation of phospholipase C with the generation of DAG and InsPs seems to be one mechanism by which PG formation can be enhanced in Kupffer cells33 both directly and indirectly via the activation of cPLA,. Glucagon could thus initiate a stimulatory signal for prostaglandin formation also by these pathways.
Functional Significance of the Glucagon-Induced PG Formation in Kupffer Cells. PGs, primarily PGE,, have been shown to attenuate glucagon-stimulated glycogenolysis in hepatocytes. The PG concentrations needed to inhibit glucagon-stimulated glycogen phosphorylase activity or glucose mobilization ranged from 20 to 200
The prostaglandin concentration in portal and hepatovenous blood, however, is only in the range of 1 nmol/L. Thus, to be operative in a hypothetical feedback inhibition loop, prostaglandins must be formed locally in the vicinity of hepatocytes in response to glucagon and reach the neighboring hepatocytes through paracrine diffusion not via the circulation. The current study provides evidence for such a hypothesis: glucagon-stimulated prostaglandin formation in Kupffer cells (Figs. l and 2 ) may be one possible intrahepatic source for the prostaglandins needed in the feedback loop.
Moreover, the study shows that glucagon-stimulated glycogenolysis was partially attenuated in a hepatocytemupffer cell coculture system and that this attenuation could be abolished by aspirin treatment of Kupffer cellshepatocyte cocultures (Fig. 4) . This indicates that prostaglandins produced by Kupffer cells may indeed act on nearby hepatocytes in a paracrine mechanism to attenuate glucagon-stimulated glycogenolysis.
In addition to the inhibition of PGH-synthase, aspirin inhibited the attenuation of glucagon-stimulated glycogenolysis by externally added PGEz (Fig. 4) . The mechanism of the aspirin action is almost certainly not caused by the inhibition of PGH synthase (cyclooxygenase). It is possible that aspirin interferes with the signal chain of the PGE, receptor involved, but the site of interference is currently not known. Other PGH synthase inhibitors like indomethacin, ibuprofen, and piroxicam also attenuated the inhibition by PGE, of glucagon-stimulated glycogenolysis in hepatocytes (Hespeling, Unpublished data, February, 1995). 34 In addition, indomethacin and ibuprofen stimulated glycogenolysis in hepatocytes. Thus, the mechanism of abolishment by aspirin of the inhibitory action of exogenous PGEz on the glucagon-dependent glycogenolysis remains to be defined.
Conclusion. The current study provides evidence for the following model ( Fig. 5) : glucagon stimulates glycogenolysis in hepatocytes. At the same time glucagon enhances PG formation in Kupffer cells. In turn, PGs, especially PGE, , inhibit the glucagon-stimulated glycogenolysis in hepatocytes; thereby, glucagon can feedback inhibit its own stimulatory signal on hepatic glycogenolysis by an intercellular communication mechanism between nonparenchymal and parenchymal cells.
